ArticleJournal of human immunity2026
Temporal windowing of recurrent sinusitis improves EHR-based immunodeficiency classification.
Article in Journal of human immunity, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
Recurrent sinopulmonary infections are a hallmark of common variable immunodeficiency (CVID), yet electronic health records (EHR) struggle to distinguish multiple discrete infections from a single infection comprising multiple clinic visits. Using diagnosis codes and antibiotic prescriptions, we developed a temporal windowing methodology that groups related sinusitis encounters into episodes based on timing and antibiotic escalation patterns. We applied this approach to 79 CVID patients, 224 rituximab-treated patients with hypogammaglobulinemia, and 2,994 matched controls. Immunodeficient patients had more frequent sinusitis episodes and greater episode burden than controls. Windowed episode features, when combined with infection PheCodes, yielded the best-performing Ridge regression classifiers in both the CVID-only (AUC-ROC 0.787) and pooled CVID/RTX (AUC-ROC 0.724) models, outperforming PheCodes combined with simple encounter counts and PheCodes alone. In a held-out cohort of five patients with pre-diagnosis sinusitis data, the classifier correctly flagged 4 of 5 as high-risk. Quantifying recurrence and refractoriness of infections through temporal windowing improves EHR-based phenotyping of immunodeficiency.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.